Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Br J Cancer ; 110(12): 2914-22, 2014 Jun 10.
Artículo en Inglés | MEDLINE | ID: mdl-24853178

RESUMEN

BACKGROUND: Recently, fibroblast growth factor receptor 1 (FGFR1) was discovered in squamous cell carcinomas (SCC) of the lung with FGFR1 amplification described as a promising predictive marker for anti-FGFR inhibitor treatment. Only few data are available regarding prevalence, prognostic significance and clinico-pathological characteristics of FGFR1-amplified and early-stage non-small cell lung carcinomas (NSCLC). We therefore investigated the FGFR1 gene status in a large number of well-characterised early-stage NSCLC. METHODS: FGFR1 gene status was evaluated using a commercially available fluorescent in situ hybridisation (FISH) probe on a tissue microarray (TMA). This TMA harbours 329 resected, formalin-fixed and paraffin-embedded, nodal-negative NSCLC with a UICC stage I-II. The FISH results were correlated with clinico-pathological features and overall survival (OS). RESULTS: The prevalence of an FGFR1 amplification was 12.5% (41/329) and was significantly (P<0.0001) higher in squamous cell carcinoma (SCC) (20.7%) than in adenocarcinoma (2.2%) and large cell carcinoma (13%). Multivariate analysis revealed significantly (P=0.0367) worse 5-year OS in patients with an FGFR1-amplified NSCLC. CONCLUSIONS: FGFR1 amplification is common in early-stage SCC of the lung and is an independent and adverse prognostic marker. Its potential role as a predictive marker for targeted therapies or adjuvant treatment needs further investigation.


Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/genética , Carcinoma de Pulmón de Células no Pequeñas/mortalidad , Carcinoma de Células Escamosas/genética , Amplificación de Genes , Neoplasias Pulmonares/genética , Receptor Tipo 1 de Factor de Crecimiento de Fibroblastos/genética , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Células Escamosas/mortalidad , Supervivencia sin Enfermedad , Femenino , Humanos , Hibridación Fluorescente in Situ , Neoplasias Pulmonares/mortalidad , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia/genética , Análisis de Matrices Tisulares
2.
Z Rheumatol ; 71(10): 908-10, 2012 Dec.
Artículo en Alemán | MEDLINE | ID: mdl-23090089

RESUMEN

This article reports the case of a 55-year-old man who presented with aphasia caused by intracerebral lesions and had a history of pulmonary sarcoidosis. Due to nonsteroidal anti-inflammatory drug-resistant spondyloarthritis TNF-alpha inhibitor treatment was started after a negative tuberculosis screening. Subsequently the patient developed pulmonary tuberculosis and cerebral tuberculoma reactivated by the TNF-alpha inhibitor therapy accompanied by pulmonary sarcoidosis with sacroiliitis and oligoarthritis. This case report emphasises the risk of atypical tuberculosis infections under TNF-alpha inhibitors despite negative results of tuberculosis screening.


Asunto(s)
Antiinflamatorios/efectos adversos , Sacroileítis/complicaciones , Sarcoidosis/complicaciones , Tuberculoma Intracraneal/inducido químicamente , Tuberculoma Intracraneal/diagnóstico , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Antiinflamatorios/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Sacroileítis/tratamiento farmacológico , Sarcoidosis/tratamiento farmacológico , Resultado del Tratamiento
3.
J Anal Toxicol ; 22(5): 359-62, 1998 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-9737329

RESUMEN

A rapid and selective cleanup procedure based on immunoadsorption is described for the simultaneous extraction of diazepam and its free or glucuronidated metabolites nordiazepam, temazepam, and oxazepam from urine. The method can also be used for the extraction of lorazepam and lorazepam-glucuronide. Because the samples do not have to be hydrolyzed before extraction, valuable information is preserved. With the exception of lorazepam-glucuronide, recoveries between 86 and 100% were obtained at spiking levels up to 200 ng of benzodiazepine or glucuronide per milliliter of urine. Using methanol/water (90:10, v/v) as an eluent, the immunoadsorber could be used at least 20 times. High-performance liquid chromatograms of urine samples from patients receiving low therapeutic dosages of diazepam or lorazepam are shown to demonstrate the high purity of the extracts.


Asunto(s)
Ansiolíticos/orina , Glucuronatos/orina , Técnicas de Inmunoadsorción , Diazepam/metabolismo , Humanos , Inmunoadsorbentes/metabolismo , Lorazepam/metabolismo , Lorazepam/orina , Oxazepam/orina , Temazepam/orina
4.
Cell Prolif ; 28(11): 595-607, 1995 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-8555372

RESUMEN

Pulse labelling experiments with [3H] thymidine (dT) and double labelling experiments with [3H]dT and bromodeoxyuridine (BrdUrd) were carried out on cells of the subependymal layer in the brain of adult normal mice in vivo, in vivo/in vitro and in vitro. The results should (i) lead to information about cell cycle parameters of these cells in the brain of adult mice, since these cells have been studied mostly in the rat brain up to now and (ii) answer the question whether results concerning cell proliferation obtained in vivo correspond with those from brain slices incubated in vitro with or without prelabelling in vivo. In vivo an LI of 20.2 +/- 2.7% (mean +/- SEM) and Ts = 7.2 +/- 0.7 h were found. Furthermore, grain count halving experiments led to a surprisingly short cycle time (Tc) of 11.2-14.2 h. The longer Tc values (18-20 h) reported in the literature for subependymal cells in the rat brain seem to be due to evaluations of different areas around the lateral ventricle without considering the migrating behaviour of these cells which is quite different regionally. The in vitro studies (with or without prelabelling in vivo) showed a significantly reduced LI due to the fact that about 20% of the S phase cells, possibly lying in the middle of S, stopped further DNA synthesis after transfer to culture. This was shown by comparing the cell fluxes at the G1/S and S/G2 borders of in vivo vs. in vitro studies.


Asunto(s)
Epéndimo/citología , Animales , Autorradiografía , Bromodesoxiuridina , Ciclo Celular/fisiología , División Celular/fisiología , Fase G2/fisiología , Inmunohistoquímica , Masculino , Ratones , Ratones Endogámicos , Mitosis/fisiología , Fase S/fisiología , Timidina/metabolismo , Tritio
5.
Biochim Biophys Acta ; 913(2): 245-55, 1987 Jun 17.
Artículo en Inglés | MEDLINE | ID: mdl-3297162

RESUMEN

Ribosomal proteins from Escherichia coli have been isolated by a mild purification procedure. Their tertiary structure has been explored by two techniques, proton magnetic resonance and limited proteolysis. A number of proteins when subjected to limited proteolysis produce resistant fragments in good yields. In most cases this does not depend on the specificity of the enzyme used. The proteins S15, S16, S17 and L30 are not degraded at all, whereas a few proteins are very susceptible to proteolysis. 1H-NMR experiments show that the majority of the ribosomal proteins have a uniquely folded tertiary structure. This is particularly pronounced in the four proteins mentioned above which resist proteolysis. In general, a good agreement is observed between the degree of proteolytic resistance and the amount of folding indicated by NMR spectroscopy. Similar studies on a few ribosomal proteins purified under denaturing conditions show that, in contrast, these protein preparations are not structurally homogeneous and that they contain a mixture of denatured and renatured molecules. The results are interpreted in terms of a compactly folded tertiary structure for the four proteinase-resistant proteins while the majority of the other proteins appear to have two domains, one compactly folded and resistant to proteinase and the other flexible and susceptible to proteolysis. A few proteins seem to have a completely flexible structure and can therefore be easily degraded.


Asunto(s)
Proteínas Bacterianas , Escherichia coli/análisis , Proteínas Ribosómicas , Proteínas Bacterianas/aislamiento & purificación , Hidrólisis , Espectroscopía de Resonancia Magnética , Péptido Hidrolasas/metabolismo , Péptidos/aislamiento & purificación , Conformación Proteica , Proteínas Ribosómicas/aislamiento & purificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA